These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29790003)

  • 1. Rationalizing the path to a universal graft recipient.
    Cohn M
    Immunol Res; 2018 Jun; 66(3):332-335. PubMed ID: 29790003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights into Graft-Versus-Host Disease and Graft Rejection.
    Perkey E; Maillard I
    Annu Rev Pathol; 2018 Jan; 13():219-245. PubMed ID: 29099650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic approach to graft-versus-host disease.
    El-Jawahri A; Chen YB
    J Clin Oncol; 2013 Dec; 31(35):4462-4. PubMed ID: 24166516
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.
    Cranston D; Wood KJ; Carter NP; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement.
    Sá H; Leal R; Rosa MS
    Int Rev Immunol; 2017 May; 36(3):182-203. PubMed ID: 27682364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two-way paradigm of transplantation immunology.
    Rao AS; Starzl TE; Demetris AJ; Trucco M; Thomson A; Qian S; Murase N; Fung JJ
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S46-51. PubMed ID: 8811063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of autoimmune diseases and graft rejection with anti-CD4 antibodies].
    Emmrich F; Burmester G; Horneff G; Emmrich J; Reinke P; Hiepe F; Kalden J; Schulze-Koops H; Volk HD
    Z Gesamte Inn Med; 1992 Nov; 47(11):500-7. PubMed ID: 1361089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
    Krieger NR; Fathman CG
    J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
    [No Abstract]   [Full Text] [Related]  

  • 12. [The HLA system and transplantation].
    Onizuka M; Naruse T; Inoko H
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():653-8. PubMed ID: 15861724
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation tolerance.
    Gaglia JL; Harlan DM
    Curr Dir Autoimmun; 2001; 4():283-307. PubMed ID: 11569407
    [No Abstract]   [Full Text] [Related]  

  • 14. Toll-like receptors (TLRs) in transplantation.
    Alegre ML; Chong A
    Front Biosci (Elite Ed); 2009 Jun; 1(1):36-43. PubMed ID: 19482622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation.
    Frezza EE; Gerunda GE; Fassina A; DeFranchis R; Biffi R; Gurakar A; Fagiuoli S; Maffei FA; Van Thiel DH
    Transplant Proc; 1994 Jun; 26(3):1626. PubMed ID: 8030063
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.
    Helg C; Chapuis B; Bolle JF; Morel P; Salomon D; Roux E; Antonioli V; Jeannet M; Leski M
    Transplantation; 1994 Dec; 58(12):1420-2. PubMed ID: 7809937
    [No Abstract]   [Full Text] [Related]  

  • 17. Engraftment of allogeneic bone marrow cells: experimental investigations on the role of cell dose, graft-versus-host reactive T cells and pretransplant immunosuppression.
    Uharek L; Glass B; Gassmann W; Eckstein V; Steinmann J; Loeffler H; Mueller-Ruchholtz W
    Transplant Proc; 1992 Dec; 24(6):3023-5. PubMed ID: 1466042
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolongation of cardiac allograft survival in rats by immunization with antibody-coated blood cells: changes in the T-cell compartment.
    Terness P; Thies JC; Koru T; Daniel V; Otto G; Süsal C; Opelz G
    Transplant Proc; 1992 Dec; 24(6):2562-4. PubMed ID: 1465867
    [No Abstract]   [Full Text] [Related]  

  • 19. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.